Significant Contract Modifications ($10M+) — June 12, 2026

Partner Therapeutics won a $133.5M firm-fixed-price delivery order from HHS/ASPR for Leukine, with $83.5M already outlaid, providing strong near-term revenue visibility through March 2027. This signals durable demand for pharmaceutical preparedness products.

MANTECH won a $452M cost-plus-fixed-fee contract from GSA FEDSIM for R&D services through June 2027, implying ~$60M annual revenue. The full-and-open competition win signals strong competitive standing in government R&D.

MAXIMUS secured a $92.3M firm-fixed-price BPA call from the IRS for IT systems support through May 2029, strengthening its position in federal IT services. Only $30.6M outlaid suggests phased funding, creating upside if options are exercised.

Caddell Construction won a $322.4M firm-fixed-price contract for the Rio New Consulate Compound. The fixed-price structure transfers all cost overrun risk to the contractor, making execution performance critical to margin protection.

JAG KETCHIKAN's $99.6M firm-fixed-price NOAA ship modernization contract (2026-2029) exposes the small business to significant cost overrun risk on a complex maritime project. Any execution misstep could materially impact its financials.

The digest shows heavy civilian agency concentration (9 of 10 contracts), with only one defense-related award. This limits exposure to DOD's $400B+ budget and makes the portfolio vulnerable to civilian budget cuts or CR-driven delays.

The $452M MANTECH GSA contract and $290.8M SAIC GSA contract are both cost-plus, which provides margin protection but exposes the government to cost growth. In a tight budget environment, such contracts may face scrutiny or delayed funding.

ACUMEN LLC's $167.3M CMS DATALINK contract is a time-and-materials delivery order with 89.5% already outlaid, suggesting near-complete performance. The lack of exercised options beyond the base period raises re-compete risk.

MANTECH's $452M GSA R&D contract through 2027 provides a stable ~$60M annual revenue stream, with potential for follow-on task orders under the same IDIQ vehicle. Investors should monitor quarterly filings for revenue contribution.

MAXIMUS's $92.3M IRS IT modernization BPA call has only $30.6M outlaid, leaving ~$61.7M in potential future funding. Full exercise of options could increase total value to $94.1M, signaling sustained IRS IT investment.

With only 1 of 10 contracts defense-related, there is a notable gap in DOD exposure. Defense-focused investors should watch for re-compete opportunities or new awards in areas like C4ISR, cyber, and logistics where SAIC and MANTECH compete.

Four contracts totaling $947M (MANTECH $452M, SAIC $290.8M, Peraton $121.6M, MAXIMUS $92.3M) are for IT and R&D services from civilian agencies (GSA, IRS), indicating sustained demand for technology modernization outside the DOD.

Three HHS contracts (Partner Therapeutics $133.5M, ACUMEN $167.3M, CTIS $85.6M) totaling $386.5M highlight bipartisan support for medical preparedness and health IT, with Partner Therapeutics' Leukine contract signaling durable demand for pharmaceutical stockpiles.

Two large firm-fixed-price construction contracts (Caddell $322.4M State Department, JAG KETCHIKAN $99.6M NOAA) total $422M, reflecting government investment in diplomatic and research infrastructure. However, fixed-price pricing transfers cost risk to contractors.

{"entity"=>"MANTECH INTERNATIONAL CORPORATION", "reason"=>"Largest contract in the digest ($452M) with multi-year revenue visibility. Key to track revenue contribution and follow-on task orders.", "trigger"=>"Quarterly earnings reports showing revenue from the GSA FEDSIM R&D contract; any new task order announcements under the same vehicle"}

{"entity"=>"Partner Therapeutics, Inc.", "reason"=>"Private company with $133.5M HHS contract; potential acquisition target or IPO candidate given durable government revenue.", "trigger"=>"Press releases on strategic partnerships, acquisition rumors, or IPO filings"}

{"entity"=>"MAXIMUS FEDERAL SERVICES, INC.", "reason"=>"Only $30.6M outlaid on a $92.3M IRS contract; upside if options are exercised. Key to monitor execution pace.", "trigger"=>"IRS budget announcements for IT modernization; modification or option exercise on the BPA call"}

{"entity"=>"JAG KETCHIKAN, LLC", "reason"=>"Small business with $99.6M fixed-price NOAA contract; execution risk is high. Any cost overrun disclosure would be material.", "trigger"=>"Progress reports on NOAA Ship Henry B. Bigelow modernization; contract modifications indicating cost overruns"}